Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
US8388972B2 · kind B2 · utility
2Cited by
0References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 12, 2007 |
| Grant date | Mar 5, 2013 |
| Priority date | — |
| Expiry date | May 1, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Antibody or fragment thereof, which specifically binds to folate receptor-alpha (FRα), wherein said antibody or fragment thereof comprises a light chain whose variable region comprises at least one of the following amino acid sequences: —RASESVSFLGINLIH (SEQ ID NO: 3), —QASNKDT (SEQ ID NO: 4), —LQSKNFPPYT (SEQ ID NO: 5), and wherein the constant region of said light chain is a kappa constant region.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.